Literature DB >> 19418825

Anthracycline-induced cardiotoxicity: risk assessment and management.

Maysa M Abu-Khalaf1, Lyndsay Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19418825

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  4 in total

1.  Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.

Authors:  Antonio Antón; Agustí Barnadas; Jesús Florián; Nuria Ribelles; María Lomas; Juan Lao; Ana González-Quintás; Mireia Margelí; Ana Belén Paules; Javier Gayo; Manuel Ramos
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

Review 2.  Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.

Authors:  Simon Binder; Andrew L Lewis; J-Matthias Löhr; Michael Keese
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 3.  Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors.

Authors:  Amy A Kirkham; Margot K Davis
Journal:  J Oncol       Date:  2015-08-03       Impact factor: 4.375

4.  Cardiotoxicity and cardiovascular disease risk assessment for patients receiving breast cancer treatment.

Authors:  Robyn A Clark; Tania S Marin; Narelle M Berry; John J Atherton; Jonathon W Foote; Bogda Koczwara
Journal:  Cardiooncology       Date:  2017-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.